(St. Louis INNO) Fire Awards 2024: Peptyde Bio validates Danforth Center investment strategy

Peptyde Bio was recognized as the 2023 Top Deal at the INNO Fire Awards. The startup launched by the Danforth Technology Company (DTC) in 2022 was acquired by Invaio Sciences in December 2023. The quick acquisition of Peptyde Bio by Invaio is a proof point that the DTC approach works. This breakthrough makes funding and developing the next Danforth Center companies easier and stands as a key milestone for DTC. For Peptyde Bio, the acquisition has enabled the combination of a novel group of potent nature-derived anti-microbial peptides together with Invaio's talented team of experienced scientists and agriculture specialists and their groundbreaking biological delivery systems.

Read the full St. Louis Inno article!